¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"maximum and minimum thermometer"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
maximum expiratory flow rate
ÃÖ°í³¯¼ûÀ¯¼Ó, ÃÖ°íÈ£±âÀ¯¼Ó
maximum flow rate
1. ÃÖ°íÀ¯¼Ó 2. ÃÖ°íÈ帧¼Óµµ 3. ÃÖ´ëÀ¯·®
maximum gradient strength
ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°µµ
maximum heart rate
ÃÖ´ë½ÉÀå¹Úµ¿¼ö, ÃÖ´ë½É¹Ú¼ö
maximum intensity projection
ÃÖ´ë°µµÅõ»ç
maximum midexpiratory flow
ÃÖ´ëÁß°£³¯¼ûÀ¯·®, ÃÖ´ëÁß°£È£±âÀ¯·®
maximum oxygen debt
ÃÖ´ë»ê¼ÒºÎä
maximum permissible concentration
ÃÖ´ëÇã¿ë³óµµ
maximum permissible level
ÃÖ´ëÇã¿ë¼öÁØ
maximum permissible limit
ÃÖ´ëÇã¿ëÇѰè
maximum phonation time
ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
maximum power output
ÃÖ´ëÃâ·Â
maximum safe intensity level
ÃÖ´ë¾ÈÀü°µµ¼öÁØ
maximum security unit
ÃÖ´ë¾ÈÀüº´µ¿
maximum tolerance dose
1. ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·® 2. ÃÖ´ë°ßµõ¼±·®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
maximum allowable concentration
ÃÖ´ëÇã¿ë³óµµ
maximum permissible concentration
ÃÖ´ëÇã¿ë³óµµ
maximum urea clearance
ÃÖ°í¿ä¼Òû¼Ò, ÃÖ°í¿ä¼Òû¼ÒÀ²
maximum dose
ÃÖ´ë¿ë·®, ÃÖ´ë¼±·®
maximum allowable dose
ÃÖ´ëÇã¿ë·®
maximum oxygen debt
ÃÖ´ë»ê¼ÒºÎä·®
maximum tolerance dose
ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·®, ÃÖ´ë°ßµõ¼±·®
maximum midexpiratory flow
Ãִ볯¼ûÁß°£À¯·®
maximum acceptable daily intake
ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®
maximum allowable limit
ÃÖ´ëÇã¿ëÇѰè
maximum permissible level
ÃÖ´ëÇã¿ë¼öÁØ
maximum permissible limit
ÃÖ´ëÇã¿ëÇѰè
maximum safe intensity level
ÃÖ´ë¾ÈÀü°µµ¼öÁØ
maximum
ÃÖ´ë
maximum transport
ÃÖ´ë¿î¹ÝÄ¡, ÃÖ´ëÀ̵¿Ä¡
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
8
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
personality, anxious and fearful
ºÒ¾È°øÆ÷¼º ÀΰÝ
pharmacy and therapeutic committee
¾à»çÀÇ·áÀ§¿øÈ¸(ËâË×ËöËíËôËôÌ·) º´¿ø(ËÓ Ëô)ÀÇ .
pneumocyte, types i and ii
ÆóÆ÷¼¼Æ÷(øËøàá¬øà), IÇü°ú IIÇü
porokeratotoic eccrine ostial and dermal duct nevus
ÇѰø°¢ÈÁõ¼º ¿¡Å©¸°±¸¸Û ¹× ÁøÇǰü¸ð¹Ý
positional and postural vertigo
µÎÀ§ ¹× üÀ§ º¯È¯(¼º) Çö±â
pruritic urticarial papules and plaqes of pregnany
ÀӽŠ¼Ò¾ç¼º µÎµå·¯±â¼º ±¸Áø ¹× ÆÇ
pulmonary congestion and edema
Æó¿ïÇ÷(øËê¦úì) ¹× ÆóºÎÁ¾(øËÝ©ðþ)
release of information and confidentiality
Á¤º¸¿Í ºñ¹Ð´©¼³(ÝúÚËÒèàÜ)
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
minimum hemolytic dose
ÃÖ¼Ò¿ëÇ÷·®(õÌá³é»úìåÖ) º¸Ã¼ÀÇ .
minimum inhibitory concentration
ÃÖ¼Ò¹ßÀ°ÀúÁö³óµµ(õÌá³Û¡ëÀîÁòÒØöô).
minimum inhibitory concentration
ÃÖ¼Ò¾ïÁ¦³óµµ
minimum inhibitory concentration
ÃÖ¼Ò¹ßÀ°ÀúÁö³óµµ(̧ËÛËÑËôËøÌ¤ËÀ̬).
minimum inhibitory dose
ÃÖ¼Ò¾ïÁ¦·®(¡åäð¤åÖ).
minimum legible
ÃּҺи®´É(¡ÝÂìÆÒö).
minimum legible acuity
ÃÖ¼Ò°¡µ¶½Ã·Â
minimum lethal dose (MLD)
ÃÖ¼ÒÄ¡»ç·®
minimum medium
ÃÖ¼Ò(¿µ¾ç)¹èÁö(¡ç½å×ÛÆò¢).
minimum medium
ÃÖ¼Ò(¿µ¾ç)¹èÁö(¡(ç½å×)ÛÆò¢).
minimum necrotizing dose
ÃÖ¼Ò±«»ç·®(¡ÎÕÞÝåÖ).
minimum perceptable acuity
ÃÖ¼ÒÀÎÁö½Ã·Â
minimum reacting dose
ÃÖ¼Ò¹ÝÀÀ·®(¡ÚãëëåÖ).
minimum safety pressure
ÃÖ¼Ò¾ÈÀü¾Ð.
minimum separable
ºÐÇØ¿ªÄ¡(ÝÂú°ÚÊö·).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½